Primary Endpoints: The proportion of participants achieving pain remission, which is defined as the rate of participants with average NRS (Numerical rating scale) score ≤3 \[CR (Complete remission)\] or achieving a reduction of 25% when NRS score \>3 \[PR (Partial remission)\] at 72 h.
Secondary Endpoints:
* The proportions of participants with CR and PR at 24h and 48h
* Time-to-first CR and PR
* The respective proportions of participants with no rescue medication use at 24h, 48h, and 72h
* Pain severity subscale score, interference of pain subscale score from the BPI-SF
* The average titration dosage of OxyContin
* The average maintenance dosage of OxyContin
* Adverse events: the frequency and severity of adverse event
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female cancer participants, age ≥ 18 years
Participants presenting with moderate to severe (NRS ≥ 4 points) cancer-related pain
Participants undergoing outpatient titration regimen with OxyContin as background, see Appendix 3
Voluntarily sign an informed consent form
You may not be if
Participants with cognitive impairment, delirium, psychiatric disorders, or other conditions that may interfere with reliable pain self-assessment
Participants are receiving surgery or minimally invasive interventional pain management
Participants are not willing to cooperate in completing follow-up
The investigator judges as unsuitable for inclusion in the study